Product Information
CEFPROZIL 250 MG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.4814 per EA under NDC 00093107701. Its NADAC has been published 657 times since Nov 28, 2013.
Strength
250 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093107701
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CEFPROZILApproval Type
Generic (ANDA)
FDA Application
ANDA065208On Market Since
12/23/2005
Price Statistics
The NADAC for CEFPROZIL 250 MG TABLET has been published 657 times since Nov 28, 2013, and over the history we have for it it has declined 60.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4814 per EA |
|---|---|
| All-time high | $1.5445 (Feb 12, 2014) |
| All-time low | $0.4429 (Dec 21, 2022) |
| 52-week high | $0.5890 |
| 52-week low | $0.4814 |
| Median price | $0.7448 |
| Average price | $0.7413 |
| Largest weekly change | +65.4% (Sep 22, 2021) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CEFPROZIL 250 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CEFPROZIL 250 MG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $0.4814 per EA (NDC 00093107701), effective Jun 24, 2026.
How has the price of CEFPROZIL 250 MG TABLET changed over time?
Over the history we have for it, the NADAC for CEFPROZIL 250 MG TABLET has declined 60.1%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CEFPROZIL 250 MG TABLET?
Since Nov 28, 2013, the NADAC for CEFPROZIL 250 MG TABLET has ranged from a low of $0.4429 (Dec 21, 2022) to a high of $1.5445 (Feb 12, 2014), with a median of $0.7448 per EA.
Are there cheaper alternatives to CEFPROZIL 250 MG TABLET?
4 NADAC-published products share the same active ingredient, strength, and dosage form as CEFPROZIL 250 MG TABLET, but none are currently priced below it.
Who manufactures CEFPROZIL 250 MG TABLET?
CEFPROZIL 250 MG TABLET (NDC 00093107701) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification